Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Cara Therapeutics, Inc.

Report final topline results from the first pivotal study of the KOURAGE program

Not delivered by the deadline

AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.

Announced
22 Jan 2024
Due
31 Dec 2025
Checked
22 Sep 2026
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“Final topline results from the first pivotal study are expected by the end of 2025”

What we found

Evidence strength A What the grades mean

Company discontinued the KOURAGE program in June 2024 after Part A dose-finding results, preventing delivery of final pivotal study results promised by end of 2025.

Checked 22 Sep 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical readout late
Indicative materiality
High rules
Action
Report
Language
Expected (“expects”, “plans”)

How this entry was checked

  1. Commitment recordedRecorded from the company's filing.
  2. First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: disagreesGemini (Google) re-read the evidence blind and read it as “no_evidence”.
  4. Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the second check.

Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works

Are you Cara Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2024-TVRD-000029 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.